Kal Raman

Kal Raman is an accomplished technologist and businessman and has held leadership positions at companies such as Amazon, Drugstore.com and Wal-Mart. Passionate about education, Kal founded GlobalScholar in 2006 to provide instruction management software to K-12 schools. The company was acquired by Scantron Corporation in January 2011.

Recent posts

Innovating for Education: Puget Sound Businesses Can Lead the Way
Educational reform is at the top of the national agenda, and it is a particularly salient issue for the tech industry. To lead the world in innovation, we also must lead... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Nitrome Bio Bags $38M to Prep Parkinson’s Program for the Clinic

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

RDMD Lands $14M to Expand Reach of Rare Disease Research Platform

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Kal Raman

Recent posts

Innovating for Education: Puget Sound Businesses Can Lead the Way

Underwriters and Partners

Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

Robert Langer reveals secrets to early-stage biotech success

Potency Assay Development for Cell and Gene Therapy Products

Xconomy on Demand

We offer a number of ways to subscribe for free!